Evidence map›Paper›PMID 38467611›Full record

ArticleNature communications2024

Intercellular communication atlas reveals Oprm1 as a neuroprotective factor for retinal ganglion cells.

Cheng Qian, Ying Xin, Cheng Qi, Hui Wang, Bryan C Dong, Donald J Zack, Seth Blackshaw, Samer Hattar, Feng-Quan Zhou, Jiang Qian

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Microglial polarization in retinal neovascularization: Friend or foe?Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Cheng Qian *Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0003-3182-7396
Ying Xin *Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1856-0482
Cheng QiDepartment of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-5716-5020
Hui WangSection on Light and Circadian Rhythms, National Institute of Mental Health, Bethesda, MD, USA.ORCID 0009-0002-6021-2833
Bryan C DongNeuroscience Study Program, Krieger School of Arts & Sciences, Johns Hopkins University, Baltimore, MD, USA.
Donald J ZackDepartment of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Seth BlackshawDepartment of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1338-8476
Samer HattarSection on Light and Circadian Rhythms, National Institute of Mental Health, Bethesda, MD, USA.ORCID 0000-0002-3124-9525
Feng-Quan ZhouDepartment of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA. fzhou4@zju.edu.cn.ORCID 0000-0002-1525-9969
Jiang QianDepartment of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jiang.qian@jhmi.edu.ORCID 0000-0002-0476-3596
Johns Hopkins University · USCircadian (United States) · US

Funding

Section on Light and Circadian RhythmsZIAMH002964 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI HATTAR, SAMER · 2017 to 2025
$24.1M
Wilmer Core Grant for Vision ResearchP30EY001765 · NEI · JOHNS HOPKINS UNIVERSITY · PI Ji Yi · 1985 to 2026
$22.1M
Murine Mutagenesis CoreP30NS050274 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KOLODKIN, ALEX L · 2005 to 2020
$10.9M
Transcriptional regulation of retinal cell differentiation and functionR01EY020560 · NEI · JOHNS HOPKINS UNIVERSITY · PI BLACKSHAW, SETH · 2011 to 2021
$4.4M
Identification of gene regulatory networks that control proliferative and neurogenic competence in mammalian Müller gliaR01EY031685 · NEI · JOHNS HOPKINS UNIVERSITY · PI BLACKSHAW, SETH · 2020 to 2023
$2.0M
Remodeling of chromatin and transcriptomic landscape to enhance optic nerve regenerationR01EY031779 · NEI · JOHNS HOPKINS UNIVERSITY · PI QIAN, JIANG · 2020 to 2023
$1.7M
NEI NIH HHS P30 EY001765NEI NIH HHS R01 EY020560NEI NIH HHS R01 EY031685NEI NIH HHS R01 EY031779NINDS NIH HHS P30 NS050274
6 · The paper itself

Abstract

Previous studies of neuronal survival have primarily focused on identifying intrinsic mechanisms controlling the process. This study explored how intercellular communication contributes to retinal ganglion cell (RGC) survival following optic nerve crush based on single-cell RNA-seq analysis. We observed transcriptomic changes in retinal cells in response to the injury, with astrocytes and Müller glia having the most interactions with RGCs. By comparing RGC subclasses characterized by distinct resilience to cell death, we found that the high-survival RGCs tend to have more ligand-receptor interactions with neighboring cells. We identified 47 interactions stronger in high-survival RGCs, likely mediating neuroprotective effects. We validated one identified target, the μ-opioid receptor (Oprm1), to be neuroprotective in three retinal injury models. Although the endogenous Oprm1 is preferentially expressed in intrinsically photosensitive RGCs, its neuroprotective effect can be transferred to other subclasses by pan-RGC overexpression of Oprm1. Lastly, manipulating the Oprm1 activity improved visual functions in mice.

Indexed as

Neuroprotective AgentsOptic Nerve InjuriesAnimalsCell CommunicationCell DeathCell SurvivalMiceOptic NerveReceptors, Opioid, muRetinal Ganglion CellsNeuroprotective AgentsOPRM1 protein, humanReceptors, Opioid, mu

Identifiers

PMID38467611
PMCPMC11636819
OpenAlexW4392638719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.